Literature DB >> 7942160

Expression of monocyte chemoattractant protein 1 in human osteoblastic cells stimulated by proinflammatory mediators.

J F Zhu1, A J Valente, J A Lorenzo, D Carnes, D T Graves.   

Abstract

Monocyte chemoattractant protein 1 (MCP-1) is a member of the chemokine superfamily of genes that induces chemotaxis of monocytes in inflammatory processes. The effects of interleukin-1 beta (IL-1 beta), tumor necrosis factor alpha (TNF-alpha), interleukin-6 (IL-6), transforming growth factor beta (TGF-beta), platelet-derived growth factor (PDGF-BB), parathyroid hormone (PTH), and 1,25(OH)2D3 on MCP-1 expression in human osteoblastic cells were compared. Inflammatory or proinflammatory cytokines stimulated the production of MCP-1 in normal human osteoblastic cells as determined by RIA. The osteotrophic mediators PTH and 1,25(OH)2D3 and PDGF-BB had no effect on MCP-1 expression. In further studies, the steady-state mRNA and MCP-1 protein levels in two human osteoblastic cell lines, MG-63 and SaOS-2, were examined. MCP-1 expression at both the protein and mRNA levels was greatly increased by IL-1 beta and TNF-alpha. At the mRNA level, IL-1 beta and TNF-alpha strongly induced MCP-1 expression; TGF-beta and IL-6 induced MCP-1 but to a lesser extent. No significant changes in MCP-1 mRNA or MCP-1 protein secretion were observed when cells were treated with PDGF-BB, PTH, and 1,25(OH)2D3. When tested on preosteoclasts, MCP-1 was shown to have no effect on the formation of multinucleated, tartrate-resistant acid phosphatase (TRAP)-positive osteoclastic cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7942160     DOI: 10.1002/jbmr.5650090721

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  17 in total

1.  Monocyte recruitment and expression of monocyte chemoattractant protein-1 are developmentally regulated in remodeling bone in the mouse.

Authors:  S Volejnikova; M Laskari; S C Marks; D T Graves
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

Review 2.  Osteoimmunology: interactions of the bone and immune system.

Authors:  Joseph Lorenzo; Mark Horowitz; Yongwon Choi
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

3.  Understanding the host response to cell-laden poly(ethylene glycol)-based hydrogels.

Authors:  Mark D Swartzlander; Aaron D Lynn; Anna K Blakney; Themis R Kyriakides; Stephanie J Bryant
Journal:  Biomaterials       Date:  2012-11-10       Impact factor: 12.479

4.  Chemokine production by a human alveolar epithelial cell line in response to Mycobacterium tuberculosis.

Authors:  Y Lin; M Zhang; P F Barnes
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

5.  Regulation of periodontal ligament cell functions by interleukin-1beta.

Authors:  S Agarwal; C S Chandra; N P Piesco; H H Langkamp; L Bowen; C Baran
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

Review 6.  The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally?

Authors:  Teizo Yoshimura
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

7.  Giant cell tumor of bone: a neoplasm or a reactive condition?

Authors:  Anwar Ul Haque; Ambreen Moatasim
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

8.  The expression of osteoclastogenesis-associated factors and osteoblast response to osteolytic prostate cancer cells.

Authors:  Colm Morrissey; Janice S Lai; Lisha G Brown; Ya-Chun Wang; Martine P Roudier; Ilsa M Coleman; Roman Gulati; Funda Vakar-Lopez; Lawrence D True; Eva Corey; Peter S Nelson; Robert L Vessella
Journal:  Prostate       Date:  2010-03-01       Impact factor: 4.104

Review 9.  Osteoimmunology: cytokines and the skeletal system.

Authors:  Seoung-Hoon Lee; Tae-Soo Kim; Yongwon Choi; Joseph Lorenzo
Journal:  BMB Rep       Date:  2008-07-31       Impact factor: 4.778

10.  Adenyl cyclase and interleukin 6 are downstream effectors of parathyroid hormone resulting in stimulation of bone resorption.

Authors:  E M Greenfield; S M Shaw; S A Gornik; M A Banks
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.